Ebola, Herpetic Eye Disease, and Ocular Complications of Emerging Infectious Diseases

Dear Colleagues,

This Special Issue, titled “Ebola, Herpetic Eye Disease, and Ocular Complications of Emerging Infectious Diseases”, explores challenges and advancements in the prevention and treatment of emerging infectious diseases. This Special Issue features several research articles that investigate the epidemiology, diagnosis, and treatment of Ebola virus disease, herpetic eye disease, and other emerging infectious diseases.

One of the key findings of this Special Issue is the importance of a timely and accurate diagnosis in the prevention and treatment of emerging infectious diseases. Several studies featured in this Special Issue investigate the accuracy and reliability of different diagnostic tests for Ebola virus disease and herpetic eye disease, as well as the challenges involved in diagnosing other emerging infectious diseases.

This Special Issue also highlights the importance of effective treatments for emerging infectious diseases. Several studies featured investigate the efficacy of different treatments for Ebola virus disease and herpetic eye disease, as well as the potential of emerging treatments such as monoclonal antibodies.

Another important theme in this Special Issue is the need for global collaboration in the prevention and treatment of emerging infectious diseases. Several studies featured investigate the challenges of ensuring equitable access to treatments and vaccines for emerging infectious diseases, particularly in low- and middle-income countries.

Finally, this Special Issue also highlights the potential impact of emerging infectious diseases on global health security. Several studies investigate the impact of Ebola virus disease and other emerging infectious diseases on healthcare systems, as well as the potential for future outbreaks.

Overall, this Special Issue, “Ebola, Herpetic Eye Disease, and Ocular Complications of Emerging Infectious Diseases”, highlights challenges and advancements in the prevention and treatment of emerging infectious diseases. The research presented in this Special Issue highlights the need for global collaboration in addressing these challenges.

Prof. Dr. Steve Yeh
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• Eebola
• herpetic eye disease
• emerging infectious diseases
• prevention and treatment